Literature DB >> 8608973

Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1.

K Kitagawa1, A Murata, N Matsuura, K Tohya, S Takaichi, M Monden, M Inoue.   

Abstract

We report on 2 cell lines (designated OVAK-I and OVAK-II) established from an adenosarcoma, a rare variant of a malignant Mullerian mixed tumor, of the ovary. OVAK-I was not tumorigenic in nude mice and showed no responsiveness to transforming growth factor (TGF)-beta1, whereas OVAK-II was tumorigenic and had various biological properties. Light- and electron-microscopic studies showed that the morphology of the cells was converted from an epithelial to a mesenchymal form by TGF-betaI. Furthermore, the protein and mRNA expressions of the epithelial marker carcinoembryonic antigen and the mesenchymal marker vimentin were down- and up-regulated, respectively, by TGF-beta1. These findings suggested that TGF-beta1 plays a role in epithelial-mesenchymal transformation and support the single-stem-cell theory which explains the origin of malignant Mullerian mixed tumors: that the epithelial and mesenchymal components of these tumors are of common stem-cell origin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608973     DOI: 10.1002/(SICI)1097-0215(19960328)66:1<91::AID-IJC16>3.0.CO;2-E

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.

Authors:  Parag P Shah; Sham S Kakar
Journal:  Cancer Lett       Date:  2011-07-13       Impact factor: 8.679

Review 2.  Pancreatic cancer stem cells.

Authors:  Ya-Yun Zhu; Zhou Yuan
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Authors:  Iman Azimi; Hannah Beilby; Felicity M Davis; Daneth L Marcial; Paraic A Kenny; Erik W Thompson; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  Mol Oncol       Date:  2015-09-25       Impact factor: 6.603

4.  Restoring TGFbeta function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation.

Authors:  Janindra Warusavitarne; Fiona McDougall; Keshani de Silva; Rebecca Barnetson; Marinella Messina; Bruce G Robinson; Margaret Schnitzler
Journal:  Int J Colorectal Dis       Date:  2008-11-05       Impact factor: 2.571

5.  Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.

Authors:  Thuy-Vy Do; Lena A Kubba; Hongyan Du; Charles D Sturgis; Teresa K Woodruff
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

6.  Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.

Authors:  Kamisha T Woolery; Patricia A Kruk
Journal:  Obstet Gynecol Int       Date:  2011-06-26

7.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

8.  nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.

Authors:  Ji-Hye Ahn; Hyun-Sung Lee; Ju-Seog Lee; Yeon-Su Lee; Jong-Lyul Park; Seon-Young Kim; Jung-Ah Hwang; Nawapol Kunkeaw; Sung Yun Jung; Tae Jin Kim; Kwang-Soo Lee; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Jung-Hye Choi; Yong Sun Lee
Journal:  Nat Commun       Date:  2018-03-21       Impact factor: 14.919

9.  Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.

Authors:  Irma Virant-Klun; Natasa Kenda-Suster; Spela Smrkolj
Journal:  J Ovarian Res       Date:  2016-03-03       Impact factor: 4.234

10.  PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state.

Authors:  Kholoud Alwosaibai; Atefeh Abedini; Ensaf M Al-Hujaily; Yong Tang; Kenneth Garson; Olga Collins; Barbara C Vanderhyden
Journal:  Oncotarget       Date:  2017-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.